A 46-year-old patient presents for routine screening mammography. Family history of breast cancer consists of a maternal aunt and grandmother.
CLINICAL HISTORY
A 46-year-old patient presents for routine screening mammography. Family history of breast cancer consists of a maternal aunt and grandmother.
FINDINGS
Digital mammography reveals an irregular 2.2cm mass in the left breast, approximately 10cm from the nipple (Figure 1a-b). The mass persists on the magnification view (Figure 1c).
(Figure 1a)
(Figure 1b)
(Figure 1c)
On physical exam, no discrete mass is palpated. Ultrasound demonstrates an irregular hypoechoic mass within the left 3:30 area measuring up to 1.4cm (Figure 2).
(Figure 2)
MRI imaging performed for extent of disease demonstrates the known carcinoma measuring 2.0 x 2.2cm in the left breast (Figure 3a-b).
(Figure 3a)
(Figure 3b)
DIAGNOSIS
Vacuum assisted stereotactic needle core biopsy of the left breast 3:30 mass reveals invasive mammary carcinoma.
DISCUSSION
This case demonstrates the benefit of screening mammography in a premenopausal woman. This was a large lesion that was not palpable and was not found by the patient or her physician. This was identified on the screening mammogram which initiated additional evaluation with magnification views, ultrasound, stereotactic biopsy, and subsequent breast MRI.
Stamatia Destounis, MD, is managing partner and a radiologist at Elizabeth Wende Breast Care in Rochester, NY.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.